ETHZilla’s $250 million buyback highlights how companies are tapping crypto gains for liquidity — but analysts warn that leverage risks could turn treasuries into ticking time bombs. Ether treasury company ETHZilla, which recently pivoted from its biotechnology roots to cryptocurrency, has approved a $250 million share repurchase program — signaling that some firms may increasingly tap digital-asset gains as a source of liquidity.ETHZilla’s board of directors authorized the buyback of up to $250 million worth of its outstanding common shares, the company disclosed Monday. The company currently has 165.4 million shares outstanding.The move comes less than a month after the firm rebranded from 180 Life Sciences and made Ether (ETH) its core strategy — a pivot that helped revive its beaten-down stock. Read more ETHZilla’s $250 million buyback highlights how companies are tapping crypto gains for liquidity — but analysts warn that leverage risks could turn treasuries into ticking time bombs. Ether treasury company ETHZilla, which recently pivoted from its biotechnology roots to cryptocurrency, has approved a $250 million share repurchase program — signaling that some firms may increasingly tap digital-asset gains as a source of liquidity.ETHZilla’s board of directors authorized the buyback of up to $250 million worth of its outstanding common shares, the company disclosed Monday. The company currently has 165.4 million shares outstanding.The move comes less than a month after the firm rebranded from 180 Life Sciences and made Ether (ETH) its core strategy — a pivot that helped revive its beaten-down stock. Read more